Every person is a collection of genetic puzzle pieces. On their own, those pieces can be hard to understand, but together, ...
Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.
A genetic testing program that helps rule out a stem-cell donor due to a genetic risk for developing leukemia was pioneered in the Maritimes, and is helping to improve cancer care.
Background Mainstreaming, in which genetic testing is shifted outside clinical genetics, can improve access to genetic testing. This is being explored in several countries, including Canada, the USA ...
Actor, director, and activist Diego Luna reflects on his artistic journey, Mexican roots, and the role of storytelling in ...
Exceptional Detection Rates of Bladder Cancer Recorded in Study of Simple, Yet State-of-the-Art Test
The simple urine test correctly identified bladder cancer-associated genes in 71 of 77 patients who went on to develop a ...
As part of breast cancer awareness efforts, the Bayhealth Cancer Institute is hosting a Breast Cancer Genetics event to help ...
The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT) applauds the National Comprehensive Cancer Network (NCCN) for its newest updates to the Genetic/Familial High-Risk ...
A rare genetic mutation could help to explain why some people who don’t smoke still develop lung cancer.
Guntur will soon host a groundbreaking genetic testing lab for cancer patients, enhancing local access to advanced ...
Veracyte has acquired Convergent Genomics in a transaction valued at up to $180 million, adding the UroAmp urinary tumor DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results